Replies to post #123540 on Biotech Values

[mcbio]

In the meantime, I will be keenly following any progress with testing of specific BRAF inhibitors for patients with hairy cell leukemia to see whether it will be a useful clinical approach in managing the disease or not.

Sounds like another potential indication for MEK inhibitors as well.